# China NMPA Product Recall - Medical image processing software Picture Archiving and Communication System

Source: https://www.globalkeysolutions.net/records/china_product_recall/philips-medical-systems/63440ce4-3c96-44e3-9aab-f3fb8ec261ff/
Source feed: China

> China NMPA product recall for Medical image processing software Picture Archiving and Communication System by Philips Medical Systems published January 05, 2026. Recall level: Level 2 Recall. Philips Medical Systems Nederland B.V., with reporting from Philips (China) Investment Co., Ltd., ha

---

## Details

- Record Type: CHINA_PRODUCT_RECALL
- Title: Philips Medical Systems Nederland B.V. is voluntarily recalling its Picture Archiving and Communication System medical image processing software.
- Company Name: Philips Medical Systems
- Publication Date: 2026-01-05
- Product Name: Medical image processing software Picture Archiving and Communication System
- Recall Level: Level 2 Recall
- Recall Reason: Due to a potential issue with the Vue PACS medical image processing software, after upgrading to version 12.2.8.600, bookmarks may become unusable for repairing original measurement data during subsequent accesses.
- Discovering Company: Philips (China) Investment Co., Ltd.
- Manufacturing Company: Philips Medical Systems
- Summary: Philips Medical Systems Nederland B.V., with reporting from Philips (China) Investment Co., Ltd., has initiated a voluntary Class II recall for its Picture Archiving and Communication System (PACS) medical image processing software. This action, published by the National Medical Products Administration (NMPA) on January 5, 2026, addresses a significant issue identified in the Vue PACS software, specifically after upgrading to version 12.2.8.600. The main problem is that users may be unable to repair bookmarks during subsequent access to medical images, a deficiency attributed to the software's handling of original measurement data. This could potentially hinder the efficient review and analysis of patient scans. While the recall targets specific models and batches, the NMPA document clarifies that the affected products were neither imported into nor sold within the Chinese market. This voluntary recall demonstrates the company's commitment to ensuring product integrity and compliance with regulatory standards under the NMPA's oversight, aiming to maintain the reliability and functionality of medical imaging systems. Further details are available in the 

Company: https://www.globalkeysolutions.net/companies/philips-medical-systems/91e33b43-88a2-4a53-9bcd-1d32f1abde47/
